In contrast to IDC, 97% of DCIS specific genes were up-regulated in DCIS vs normal, including genes such as CD22, IGHM, MS4A1, BCR, RBL2, and MAP3K5 (Table S1 and Figure S3). This evidence concerns the gene RBL2 and ductal breast carcinoma in situ.